Upstate Active Clinical Trials
Study Title:Alliance A031201-Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
What is the purpose of the study?This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone acetate, and prednisone in treating patients with castration-resistant metastatic prostate cancer.
Upstate Institutional Review Board (IRB) Number:566147
Patient Age Group:Adults
Principal Investigator:Sam Benjamin, MD
Who can I contact for more information?
Name: Lynn M Agostini, AAS